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Original Article
A critical role for the ATP-sensitive
potassium channel subunit KIR6.1
in the control of cerebral blood flow
Patrick S Hosford1,2, Isabel N Christie2,3, Arun Niranjan3,
Qadeer Aziz1, Naomi Anderson1, Richard Ang2,
Mark F Lythgoe3, Jack A Wells3, Andrew Tinker1 and
Alexander V Gourine2
Abstract
KIR6.1 (KCNJ8) is a subunit of ATP sensitive potassium channel (KATP) that plays an important role in the control of
peripheral vascular tone and is highly expressed in brain contractile cells (vascular smooth muscle cells and pericytes).
This study determined the effect of global deletion of the KIR6.1 subunit on cerebral blood flow, neurovascular coupling
and cerebral oxygenation in mice. In KIR6.1, deficient mice resting cerebral blood flow and brain parenchymal partial
pressure of oxygen (PO2) were found to be markedly lower compared to that in their wildtype littermates. However,
cortical blood oxygen level dependent responses triggered by visual stimuli were not affected in conditions of KIR6.1
deficiency. These data suggest that KATP channels containing KIR6.1 subunit are critically important for the maintenance
of normal cerebral perfusion and parenchymal PO2 but play no significant role in the mechanisms underlying functional
changes in brain blood flow.
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Introduction
Neurovascular coupling dynamically regulates the
blood supply to active brain areas to match metabolic
demand and supply.1 In pathological conditions,
including Alzheimer’s disease,2 hypertension,3 stroke,4
traumatic brain injury5 and glioma,6 compromised
cerebral blood flow (CBF) may contribute to the devel-
opment and/or progression of the disease, highlighting
the importance of understanding the mechanisms con-
trolling resting and dynamic CBF.
Ion channels that determine the membrane potential
of cerebrovascular smooth muscle cells (potassium
channels for example) are likely to be important for
the control of CBF (for review see Longden et al.7).
Even small increases in extracellular potassium can
have a profound effect on vascular tone by activating
inwardly rectifying potassium channels expressed in the
vascular smooth muscle cells.8,9 Recent data suggest
that KIR2.1 potassium channels mediate the effect of
increased extracellular Kþ on cerebral vasculature and
contribute to the operation of mechanisms underlying
increases in local CBF which follow changes in neur-
onal activity.10
Another notable family of Kþ channels include
ATP-sensitive potassium channels (KATP). In the per-
iphery, KIR6.1 plays an important role in determining
resting vascular tone, peripheral resistance and,
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therefore, systemic arterial blood pressure. Global
KIR6.1 deficiency in an animal (mouse) model was
reported to be associated with chronically elevated
(by 20mmHg) systemic arterial blood pressure.11
In the brain, drugs which promote opening of KATP
channels were reported to induce dilations of basilar
and middle cerebral arteries in a rat model.12
KIR6.1 is also abundantly expressed by brain peri-
cytes and was previously suggested to be used as a
molecular marker of this cell type.13 Evidence is accu-
mulating that these contractile cells play a critical role
in neurovascular coupling,14,15 although this idea has
been disputed.16,17 KATP channel activation hyperpo-
larises pericytes as demonstrated in retinal microvascu-
lature.18 As KATP channels are sensitive to changes
in intracellular concentrations of ATP/ADP, this
positions KIR6.1 as a possible metabolic sensor of
pericytes.
In this study, we determined the effect of global dele-
tion of the KIR6.1 channel on resting CBF, cerebrovas-
cular reactivity to CO2, neurovascular coupling and
brain tissue PO2 in mice. The data obtained suggest
that KIR6.1 is critically important for the maintenance
of normal cerebral perfusion and oxygenation but
plays no significant role in the generation of blood




The experiments were performed on 35 male mice (two
to three months old) in accordance with the European
Commission Directive 86/609/EEC (European
Convention for the Protection of Vertebrate Animals
used for Experimental and Other Scientific Purposes)
and the United Kingdom Home Office (Scientific
Procedures) Act (1986) with project approval from
the Institutional Animal Care and Use Committee.
The results of the animal experimentations are reported
in accordance with ARRIVE guidelines.
Generation of the KIR6.1 knockout mouse strain has
been previously described in detail.11 Briefly, crossing
homozygous KIR6.1 floxed mice with a mouse ubiqui-
tously expressing Cre recombinase on a C57Bl-back-
gound produced mice with global deletion of one
allele of KIR6.1. The progeny were then backcrossed
onto a C57Bl/6 background for at least six generations.
Resulting KIR6.1
þ/ mice were then crossed to produce
homozygotes.
The animals were housed in a temperature con-
trolled room at 21 2C and a relative humidity of
55 10%, with a 12-h light/12-h dark cycle with a
30min twilight period.
fMRI and analysis
All MRI experiments were performed using a 9.4T
MRI scanner (Agilent Inc.), a 72mm inner diameter
volume coil for radio frequency transmission (Rapid
Biomedical) and a 2-channel array surface coil (Rapid
Biomedical) for signal reception.
The animals were anaesthetised with isoflurane
(4–5% in O2) and placed in the scanner bore.
Medetomidine (0.4mgkg1 bolus, followed by infusion
0.8mgkg1 h1, s.c.) was administered to induce and
maintain deep sedation for the duration of the experi-
ment. Isoflurane was discontinued and the mice were
free breathing with body temperature maintained
at 37 1C using a servo-controlled heating blanket.
A nose cone was used to deliver oxygen enriched
(30%) air and to apply CO2 challenges. To stimulate
visual sensory pathways, 2Hz pulses of cold white light
were delivered to the scanner bore so that light reflected
off the surface of the head coil stimulated the eyes with
diffuse light. The stimulus was delivered using a block
design paradigm of 40 s rest, 20 s activation, repeated
three times.
Arterial spin labelling (ASL) was used to measure
CBF at rest and during systemic hypercapnia.
Baseline cerebral perfusion in the cortex was mapped
using a flow sensitive alternating inversion recovery
sequence with a three shot segmented gradient echo
EPI readout (TE¼ 5.8ms, TR¼ 5 s, TI¼ 2 s, 3 slices,
1mm slice thickness). Repeated ASL images (acquired
every 30 s) were captured for 10min at baseline condi-
tions, during 5min of CO2 challenge (5% CO2 in the
inspired gas mixture), and during a 3.5min period of
recovery. This experimental protocol was repeated
three times for each the animal. Maps of CBF were
generated by fitting the data to the established model
(Buxton et al., 1998). The mean CBF within the cortex
was plotted from manually drawn regions of interest
(ROI). [AQ1]
The fMRI methods used in this study were described
in detail elsewhere.19,20 Briefly, anatomical reference
scans were acquired using a fast spin echo sequence
(TR/TEeff¼ 4000/48ms, ETL¼ 8, matrix size¼ 192
192, FOV¼ 35 35mm2, 35 coronal slices each
0.6mm thick). Functional data were acquired using
four snapshot GE-EPI sequence (FOV¼ 35 35mm2,
matrix size¼ 96 96, 12 coronal slices each 0.5mm
thick, slice gap 0.1mm, spectral width¼ 178.6 kHz,
TR¼ 2.5 s, TE¼ 19ms, 131 volumes including one
triple reference scan, total scan time approximately
5.5min). Each subject underwent one anatomical refer-
ence scan and two fMRI scans.
Acquired fMRI data were analysed offline using
NiftyReg,21 in-house MATLAB 2013a scripts and
SPM12,22 as previously described.20 Brain anatomical
reference images were registered to the Allen Mouse
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Brain Atlas23 using an affine registration via an MRI
template. Each affine transformation matrix was then
applied to the individual fMRI data to normalise each
subject into the atlas space. The registration was eval-
uated by visual inspection using SPM12 and the Mouse
Brain Atlas.24 After registration, the fMRI data were
realigned, corrected for differences in slice timing
and smoothed (Gaussian FWHM of two voxels).
Scans were screened for artefacts (gross motion,
Nyquist ghosting and signal drop-out due to B0 field
inhomogeneities) by visual inspection performed by
the investigator blinded to the nature of the experimen-
tal group. After screening, three subjects were
excluded from the analysis (two KIR6.1 knockout and
one wildtype mice), giving final group sizes indicated in
Figure 1. ROI-based analysis was conducted by using
Figure 1. Resting cerebral blood flow (CBF), cerebrovascular reactivity to CO2, and blood oxygen level dependent (BOLD) fMRI
responses in the visual cortex in mice lacking KATP channel subunit KIR6.1. (a) Representative arterial spin labelling brain maps
illustrating measurements of CBF at baseline, during CO2 challenge (5% CO2 in the inspired gas mixture) and following recovery in a
KIR6.1 knockout (KO) mouse (7 CBF maps of the total time series of 22 are shown); (b) Mean time-course of the whole brain CBF
determined using arterial spin labelling MRI in KIR6.1 knockout and wildtype mice at resting conditions and in response to CO2
challenge; (c) Summary data illustrating resting CBF and peak increases in CBF in response to CO2 in KIR6.1 deficient and wildtype
mice; (d) Representative BOLD activation maps (FWE, familywise error, P< 0.05, nv¼ 3) taken at two coronal (top, distance from
Bregma is indicated) and two sagittal (bottom, distance from the midline is indicated) levels showing activation of visual pathways in the
brain of a KIR6.1 knockout mouse and BOLD response curves illustrating changes in mean signal within the primary visual cortex (V1)
induced by visual stimulation (20 s) in KIR6.1 knockout and wildtype mice. SC: superior colliculus. Data are presented as individual
values and/or means SEM.
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MRI atlas labels to determine time courses using the
MarsBaR toolbox. Bilateral ROIs were chosen for
timecourse extraction within V1 of the mouse visual
cortex (region code VISp in the Allen Mouse Brain
Atlas). BOLD signals were calculated by subtracting
the mean baselines value from the mean BOLD
values acquired during each stimulation epoch. All
experiments were performed blindly and all the ana-
lyses were done by individuals blinded to the nature
of the experimental groups.
Brain parenchymal PO2 measurements
Anaesthesia was induced and maintained with isoflur-
ane (5% induction, 2–3% maintenance). Core tempera-
ture was kept at 37C using a heating blanket.
Carotid artery was cannulated to record systemic arter-
ial blood pressure. The animal was placed in a stereo-
taxic frame and the skull was exposed. A small hole was
drilled in the parietal bone above the primary visual
cortex (V1) using the following coordinates: 1.0mm
rostral to lambda and 2.5mm lateral from the midline.
The dura was punctured and an OxyliteTM optical
oxygen sensor (Oxford Optronix) was lowered into
the cortical tissue to a depth of 1mm from the surface
of the brain. The craniotomy was then sealed with a
layer of petroleum jelly to prevent diffusion of ambient
oxygen. Parenchymal PO2 sampling continued for
10min until a stable reading was achieved. PO2,
PCO2 and pH of the arterial blood were measured
using a Siemens blood gas analyser (RapidLab 248).
Data were analysed off-line using Spike 2 software
(Cambridge Electronic Design).
Statistics
Differences in grouped mean data were tested for sig-
nificance using Wilcoxon’s signed rank test or Mann–
Whitney test, where appropriate. Differences with
p< 0.05 were considered to be significant
Results
ASL method was first used to quantify CBF in the wild-
type and KIR6.1 deficient mice (Figure 1(a) to (c)).
Resting CBF was found to be lower in KIR6.1 knockout
animals compared to that recorded in their wildtype
littermates (186 16 vs. 244 21ml 100 g1min1;
p¼ 0.02). However, CBF CO2 responses were not
affected in conditions of KIR6.1 deficiency. In response
to a CO2 challenge (5% inspired CO2; 5min; increase in
the arterial PCO2 from 443 to 66 3mmHg), CBF
increased from 244 21 to 263 21ml 100 g1min1 in
wildtype animals (0.35% CBF per mmHg arterial
PCO2) and from 186 16 to 203 15ml 100 g
1min1
in KIR6.1 knockout mice (0.44% CBF per mmHg
arterial PCO2). Thus, although resting CBF was signifi-
cantly lower in KIR6.1 knockout animals, there was no
difference in the magnitude of CO2-induced cerebrovas-
cular responses between the groups (CBF increased by
19.0 5 vs. 17.8 6ml 100 g1min1 in the wildtype
and KIR6.1 knockout mice, respectively; p¼ 0.438)
(Figure 1(c)).
Sensory-evoked BOLD functional magnetic reson-
ance imaging (fMRI) responses were next assessed in
the primary visual cortex of KIR6.1 knockout mice and
their wildtype counterparts (Figure 1(d)). The time
course data show that the magnitude and profile of
cortical BOLD responses triggered by visual stimuli
were not affected in conditions of KIR6.1 deficiency.
Peak BOLD responses were 1.2 0.6 % in the wild-
type mice and 1.3 0.4 % in KIR6.1 knockout mice
(Figure 1(d)).
Due to the recorded differences in resting CBF
between the wildtype and KIR6.1 deficient mice
(Figure 1(b) and (c)), we next determined whether
reduced cerebral perfusion is associated with altered
brain tissue PO2. Parenchymal PO2 was measured in
the visual cortex in animals’ breathing room air under
isoflurane anaesthesia. Mean systemic arterial blood
pressure was found to be significantly higher in
KIR6.1 knockout animals compared to that in wildtype
mice (85 6 vs. 70 2mmHg; p¼ 0.04) (Figure 2(a)),
confirming data obtained in conscious KIR6.1 deficient
mice.11 Although, the arterial blood pressure was
higher, KIR6.1 knockout animals were found to have
a significantly lower brain parenchymal PO2 than their
wildtype counterparts (23.3 6.4 vs. 45.1 4.0mmHg;
p¼ 0.035) (Figure 2(b)). There were no differences in
the arterial PO2, PCO2 and pH (7.34 0.03, n¼ 6 vs.
7.38 0.04, n¼ 6; p¼ 0.9) between KIR6.1 deficient and
wildtype mice (Figure 2(c) to (d)).
Discussion
In this study, we tested the hypothesis that KATP chan-
nels containing the KIR6.1 subunit (highly expressed by
vascular smooth muscle cells and pericytes) maintain
cerebrovascular tone and, therefore, play an important
role in the control of CBF. The data obtained dem-
onstrate that KIR6.1 deficiency in mice is associated
with a significant reduction in basal CBF and brain
tissue PO2, despite normal level of arterial oxygenation
and higher systemic arterial blood pressure.
Cerebrovascular reactivity to CO2 and sensory-evoked
BOLD fMRI responses in the visual cortex (a measure
of neurovascular coupling) were not affected in condi-
tions of KIR6.1 deficiency.
Central to our original hypothesis, KIR6.1 channel
activity can be modulated by various metabolic signals
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(such as increased energy demand or changes in pH)
and, therefore, play a certain role in the mechanisms
underlying cerebrovascular responses to increased
neuronal activity.25,26 This hypothesis was supported
by the evidence of strong KIR6.1 subunit expression
in the arterial smooth muscle cells and brain peri-
cytes.13 Despite high expression of KIR6.1 in contractile
brain cells that regulate cerebrovascular tone and the
molecular properties of KIR6.1 underlying detection
and integration of metabolic signals, this channel
appears to be dispensable for neurovascular coupling
(as measured by the BOLD response).
Although KIR6.1 channel activity is sensitive to
pH,25 KIR6.1 deletion had no effect on cerebrovascular
reactivity to CO2, suggesting that this ATP and H
þ
sensitive channel is not involved in dynamic regulation
of CBF. However, a significant limitation in interpret-
ation of these results is that cerebrovascular responses
to CO2 recorded in both KIR6.1 deficient and wildtype
mice were markedly smaller compared to typical cere-
brovascular CO2 reactivity of 2–4% CBF change per
mmHg of arterial PCO2 reported in other published
studies, including data obtained by our group in iso-
flurane-anaesthetised mice.27 In the current study, ASL
was performed under medetomidine sedation, which is
the latest popular sedative for rodents in fMRI experi-
ments. As hypercapnic challenge led to significant
increases in the arterial PCO2, these data suggest that
medetomidine may impair cerebrovascular reactivity.
Although identical experimental protocols were applied
to knockout and wildtype mice and similar absolute
increases in CBF during hypercapnia in these two
cohorts were recorded, we cannot exclude that Kir6.1
channels contribute to cerebrovascular CO2 reactivity
in an unanaesthetized state or when studied using
anaesthetics other than medetomidine.
Our data provide the first evidence that KATP
channel activity is critically important for the control
of basal CBF. KIR6.1 involvement in the control of
brain perfusion is likely to be exerted at the level of
cerebral supply vessels. This hypothesis is supported
by the evidence that compounds which promote open-
ing of KATP channels induce dilations of basilar and
middle cerebral arteries.12 There is also evidence that
pharmacological blockade of KATP channels can trigger
constrictions of some cerebral vessels, including dural28
and middle meningeal arteries.29
[AQ2]An earlier study reported that in mice global
KIR6.1 deficiency is leading to the development of sys-
temic arterial hypertension,11and the phenotype is
Figure 2. Reduced parenchymal partial pressure of oxygen (PO2) in the visual cortex in mice lacking KATP channel subunit KIR6.1.
Summary data illustrating mean arterial blood pressure (MAP) (a) resting brain tissue PO2 (b), arterial PO2 (c), and arterial PCO2 (d) in
KIR6.1 knockout (KO) and wildtype mice. Data are presented as individual values and means SEM.
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consistent with the role of this channel in determining
peripheral vascular tone. However, there is evidence
that brain hypoxia may contribute to the development
of systemic hypertension by the recruitment of the
brainstem hypoxia-sensitive mechanism, mediated by
astrocytes,30 leading to enhanced central sympathetic
drive.31 It is possible that reduced cerebrovascular
flow and brain hypoxia observed in KIR6.1 deficient
animals contribute to the development of hypertensive
phenotype in this model.
In summary, the data obtained in the present study
suggest that KIR6.1 is critically important for the main-
tenance of normal cerebral perfusion and brain tissue
PO2, which ensures brain longevity. KIR6.1 appears to
be dispensable for functional dynamic changes in CBF.
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